Australia · Delayed Price · Currency is AUD ImpediMed Company Description
ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally.
The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed for early lymphedema detection; BodyComp Analysis; Segmental BodyComp Analysis; and HF-Dex Analysis for Heart Failure.
It also provides Lymphedema Prevention Program; and BodyComp Analysis for survivorship health. The company specializes in cancer survivorship, heart health management, medical weight management, wellness, and research.
ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California.
| Country | Australia |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 66 |
| CEO | Erik Anderson |
Contact Details
Address: 5900 Pasteur Court Carlsbad, California 92008 United States | |
| Phone | 760 585 2100 |
| Website | impedimed.com |
Stock Details
| Ticker Symbol | IPD |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000IPD8 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Erik Anderson | Chief Executive Officer, MD and Director |
| McGregor Grant BEc, C.A., FCIS, GAICD | Chief Financial Officer and Executive Director |
| Julie Kuhlken | Senior Director of Marketing |
| Erik Johnson | Head of Sales |
| Ashley Munoz | Director of Human Resources |
| Scott Long | Senior Vice President of US Sales, Key Accounts, and Renewals |
| Leanne Ralph AAICD, ACIS, BBus | Company Secretary |